Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark

Physicians Can Lead Health Care Reform Through Payment And Delivery System Reforms
Physicians can and should play a leading role in achieving health care reform by working towards comprehensive reform of the way health care is paid for and delivered, helping achieve a guaranteed 1.5 percent annual savings in health care costs that would pay for covering all Americans, according to a New England Journal of Medicine Perspective piece published online.
generic viagra online
A Combination Of Micronutrients Is Beneficial In Reducing The Incidence Of Prostate Cancer And Increasing Survival In The Lady Transgenic Model
UroToday.com - Dietary micronutrients are a common component of people"s diet as they seek to prevent cancer and other diseases. Micronutrients protect against cellular oxidative damage by neutralizing oxygen free radicals. In the May 2009 issue of Cancer Prevention Research, Dr. VasundaraVenkateswaran and associates tested the effects and timing of the micronutrients vitamin E (E), selenium (S), and lycopene (L) on the development of prostate cancer (CaP) in the Lady transgenic model.
News of the day
Alexion's Soliris(R) Receives 2009 Prix Galien France For Most Innovative Drug For Rare Disease
Alexion Pharma France and Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today received the 2009 Prix Galien France for Soliris® (eculizumab) in the category of medicines for rare diseases. The award recognizes the scientific innovation represented by the complement-inhibition technology of Soliris, and the impact the drug is having on the lives of patients with paroxysmal nocturnal hemoglobinuria (PNH), an ultra-rare, debilitating and life-threatening blood disorder.
Nutrition

New Cognitive Screening Test For Detecting Early Dementia

Researchers at Addenbrook"s Hospital in Cambridge published a study on bmj.com in which they explain their design and evaluation of a new cognitive test for detecting Alzeimer" disease called TYM ("test your memory") which is considered quicker and more precise than many existing tests, and which can also help diagnose early dementia. It is extremely important to develop early detection of dementia in order to administer a useful treatment. But as of today there is still no short cognitive test that is quick to use, that can examine various skills, and that is sensitive to Alzheimer"s disease. The reason for the importance of this early diagnosis is that today, an estimated 24 million people worldwide have dementia, and this figure will double every twenty years. The TYM is a simple but useful sequence of 10 tasks which includes the following: ò€¢ The ability to copy a sentence. ò€¢ Semantic knowledge. ò€¢ Calculations. ò€¢ Verbal fluency. ò€¢ Recall ability. Each task is scored with a maximum of 50 points available. The test is specifically intended for the supervisors to hardly get involved, and also designed friendly enough for non-specialist use. The trial was completed by two types of individuals. The first group was a total of 540 participants (controls) all in good physical shape aged 18 to 95 years with no history of neurological disease, memory problems or brain injury. The other group consisted of 139 patients with a confirmed diagnosis Alzheimer"s or mild cognitive impairment. The TYM test was measured against two frequently used bedside cognitive tests: 1) The mini-mental state examination 2) The Addenbrooke"s cognitive examination. The mini-mental state examination has been used for over thirty years by The National Institute for Health and Clinical Excellence (NICE) as the most reliable short cognitive test for coherent decision on which patients should de treated with drugs and monitor their response to the drug treatment. Controls completed the test in a common average time of not more than five minutes and received an average score of 47 out of 50. Patients with Alzheimer"s disease achieved much poorer scores with an average of 33 points out of 50. Patients with mild cognitive impairment scored an average of 45 out of 50. The results of the average TYM score remained steady between the ages of 18 and 70 years, with a small decline in performance after this age. Scores did not differ between men and women or by geographical background, suggesting that education and social class would have only mild effects on the TYM score. Important conclusions on the TYM test resulted in the detection of 93% of the patients with Alzheimer"s disease compared to the mini-mental state examination that could only detect a low 52%. This concludes that the TYM is a more efficient method for detecting mild Alzheimer"s disease. It is also important to mention that the TYM examines a broader range of cognitive domains in a very short period of time. The Adenbrooke"s cognitive examination seems also to be a good method in detecting mild Alzeimer"s disease. The cognitive domains tested are similar to those of the TYM, but a big inconvenience to Adenbrooke"s is that it takes much longer to administer and score with an average of 20 minutes. As a conclusion the authors mention that the TYM is an influential and valid screening test for the detection of Alzheimer"s disease. Consultant physician Claire Nicholl explains in a complementary editorial: "The usefulness of screening tests varies according to the clinical setting." "If the test your memory test is to be adopted more widely it must be validated in a range of settings and different populations", she adds. Until then, the most essential point is that clinicians should identify a test that corresponds to their clinical setting. They should develop their skills in its use to improve the identification of patients with early dementia. "Self administered cognitive screening test (TYM) for detection of Alzheimer"s disease: cross sectional study" Jeremy Brown, consultant neurologist, George Pengas, clinical research fellow, Kate Dawson, research nurse, Lucy A Brown, honorary research assistant, Philip Clatworthy, clinical research fellow BMJ 2009;338:b2030 bmj.com Written by Stephanie Brunner (B.A.) Copyright: Medical News Today Not to be reproduced without permission of Medical News Today


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009